Newsroom
23 press releases and 54 media coverage stories
Sonoma Biotherapeutics Awarded G-Rex® Grant to Advance Cell Therapy Manufacturing
PR Newswire
ScaleReady has awarded a G-Rex® Grant to Sonoma Biotherapeutics, founded by Dr. Fred Ramsdell, to accelerate scalable T-reg cell therapy manufacturing—underscoring G-Rex® as the trusted platform powering the next generation of advanced therapies.
Read the release : Sonoma Biotherapeutics Awarded G-Rex® Grant to Advance Cell Therapy ManufacturingShare: Sonoma Biotherapeutics Awarded G-Rex® Grant to Advance Cell Therapy Manufacturing
Children’s National and ScaleReady Partner to Elevate Pediatric Cell Therapy Manufacturing
PR Newswire
Through multiple G-Rex® Grants, ScaleReady and Children’s National Hospital are collaborating to advance pediatric CAR-T, VST, and TAAT programs—demonstrating how partnership and innovation can redefine the future of cell therapy manufacturing for young patients worldwide.
Read the release : Children’s National and ScaleReady Partner to Elevate Pediatric Cell Therapy ManufacturingShare: Children’s National and ScaleReady Partner to Elevate Pediatric Cell Therapy Manufacturing
CIRM Network Chooses G-Rex® to Power the Future of Cell Therapy Manufacturing
PR Newswire
Eight California CIRM network institutions received nearly $2 million in G-Rex® Grants from ScaleReady, recognizing G-Rex® as the foundation for scalable, standardized cell therapy production—and the only proven path to meeting global patient demand.
Read the release : CIRM Network Chooses G-Rex® to Power the Future of Cell Therapy ManufacturingShare: CIRM Network Chooses G-Rex® to Power the Future of Cell Therapy Manufacturing
Gates Institute Lands $300K G-Rex® Grant to Build Modular CAR-T Platform
PR Newswire
The Translational Sciences Laboratory at the Gates Institute will use a $300,000 grant from ScaleReady to leverage the G-Rex® platform in developing a modular, high-throughput CAR-T manufacturing system for next-generation cell therapies.
Read the release : Gates Institute Lands $300K G-Rex® Grant to Build Modular CAR-T PlatformShare: Gates Institute Lands $300K G-Rex® Grant to Build Modular CAR-T Platform
Sidra Medicine Receives G-Rex® Grant to Advance Pediatric CAR-T Production
PR Newswire
Sidra Medicine in Qatar has been awarded a $100,000 ﹙USD﹚ G‑Rex® Grant from ScaleReady to develop a CD19 CAR-T cell platform for pediatric oncology, including technology transfer and GMP-compliant manufacturing set-up.
Read the release : Sidra Medicine Receives G-Rex® Grant to Advance Pediatric CAR-T ProductionShare: Sidra Medicine Receives G-Rex® Grant to Advance Pediatric CAR-T Production
University of Minnesota Secures $665K in Grants to Advance Novel Cell Therapies
PR Newswire
University of Minnesota’s researchers received $665,000 via G‑Rex® Grants from ScaleReady to power development of a CAR-NK therapy for ovarian cancer, TIL therapy for solid tumors, and T-cell treatment for Batten Disease.
Read the release : University of Minnesota Secures $665K in Grants to Advance Novel Cell TherapiesShare: University of Minnesota Secures $665K in Grants to Advance Novel Cell Therapies
Akadeum Showcases G-Rex® Flexibility with New Microbubble Workflow
PR Newswire
Akadeum’s instrument-free microbubble process highlights the versatility of ScaleReady’s G-Rex® platform, demonstrating how partners are designing innovative, scalable workflows that build on its proven foundation for efficient and flexible cell therapy manufacturing.
Read the release : Akadeum Showcases G-Rex® Flexibility with New Microbubble WorkflowShare: Akadeum Showcases G-Rex® Flexibility with New Microbubble Workflow
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
PR Newswire
The $150K G-Rex® Grant supports Immuneel’s shift to more efficient, scalable CAR-T cell manufacturing in India. This collaboration aims to accelerate access to life-saving cell therapies by reducing production complexity and cost.
Read the release : ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel TherapeuticsShare: ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ScaleReady awards multiple G-Rex® Grants to leading investigators at USC and CHLA
PR Newswire
ScaleReady and its partners have awarded four G-Rex® Grants totaling over $1M to leading researchers at USC and CHLA to accelerate innovative CAR-T and T cell therapy programs targeting solid tumors and pediatric cancers.
Read the release : ScaleReady awards multiple G-Rex® Grants to leading investigators at USC and CHLAShare: ScaleReady awards multiple G-Rex® Grants to leading investigators at USC and CHLA
ScaleReady awards a G-Rex® Grant to A2 Biotherapeutics, Inc.
PR Newswire
A2 Biotherapeutics receives a $300,000 G-Rex® Grant to support scalable CAR-T manufacturing and process development using its Tmod™ platform for solid tumor therapies.
Read the release : ScaleReady awards a G-Rex® Grant to A2 Biotherapeutics, Inc.Share: ScaleReady awards a G-Rex® Grant to A2 Biotherapeutics, Inc.
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
PR Newswire
March Biosciences has been awarded a $200,000 G-Rex® Grant from ScaleReady and partners to streamline cGMP manufacturing of its MB-105 CAR-T therapy for CD5-positive T-cell lymphomas.
Read the release : ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell TherapyShare: ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
PR Newswire
Learn how BrainChild Bio is accelerating its groundbreaking CAR-T therapy for pediatric brain cancer with a $300,000 G-Rex® Grant supported by ScaleReady and its partners.
Read the release : ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild BioShare: ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
